A prospective within-patient randomised controlled trial of the treatment of vitiligo with the 308-nm excimer laser: a pilot study
| ISRCTN | ISRCTN51633881 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN51633881 |
| Protocol serial number | N0064122126 |
| Sponsor | Department of Health (UK) |
| Funder | Sandwell and West Birmingham Hospitals NHS Trust (UK) |
- Submission date
- 12/09/2003
- Registration date
- 12/09/2003
- Last edited
- 14/05/2018
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Skin and Connective Tissue Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr SW Lanigan
Scientific
Scientific
Department of Dermatology
City Hospital
Dudley Road
Birmingham
B18 7QH
United Kingdom
| Phone | +44 (0)121 554 3801 |
|---|---|
| Sean.Lanigan@swbh.nhs.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Single centre, patient volunteers, prospective, controlled, therapeutic, observational, single-blind, devices, longitudinal, invasive procedures, randomised study. |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | A prospective within-patient randomised controlled trial of the treatment of vitiligo with the 308-nm excimer laser: a pilot study |
| Study objectives | The main purpose of this study is to determine the efficacy of the 308-nm excimer laser in the treatment of facial vitiligo which is a very cosmetically disabling disorder. This will be a prospective within patient randomised controlled trial and will investigate and quantify the repigmentation achieved with this treatment. We shall also be monitoring the side effects of the treatment if any. The other aspect of the study is to determine if the repigmentation achieved is sustained over a duration of time. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Skin and Connective Tissue Diseases: Facial vitiligo |
| Intervention | Not provided at time of registration |
| Intervention type | Other |
| Primary outcome measure(s) |
Not provided at time of registration |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 01/06/2005 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Child |
| Sex | Not Specified |
| Target sample size at registration | 48 |
| Key inclusion criteria | 17 to 48 patient volunteers will be recruited. |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 22/04/2003 |
| Date of final enrolment | 01/06/2005 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
City Hospital
Birmingham
B18 7QH
United Kingdom
B18 7QH
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
14/05/2018: Conference proceedings added.
10/05/2018: No publications found, verifying study status with principal investigator
01/03/2016: No publications found, verifying study status with principal investigator
